Cite
HARVARD Citation
Sprague, S. et al. (2021). A safety evaluation of sucroferric oxyhydroxide for the treatment of hyperphosphatemia. Expert opinion on drug safety. 20 (12), pp. 1463-1472. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sprague, S. et al. (2021). A safety evaluation of sucroferric oxyhydroxide for the treatment of hyperphosphatemia. Expert opinion on drug safety. 20 (12), pp. 1463-1472. [Online].